Previous 10 | Next 10 |
JP Morgan has downgraded Amarin Corp. (NASDAQ:AMRN) to underweight due to headwinds seen in both the U.S. and Europe. The firm also took away its price target. Analyst Jessica Fye said that U.S. volume and pricing pressures could get even worse, while in Europe, reimbursement and pricing in c...
Following a sharp selloff triggered by disappointing 1Q 2022 results, the ADRs of Amarin Corporation (NASDAQ:AMRN) continue to trade lower in the morning hours Thursday after H.C. Wainwright downgraded the maker of Vascepa cardiovascular therapy to Neutral from Buy. Outlining reasons for his ...
Image source: The Motley Fool. Amarin (NASDAQ: AMRN) Q1 2022 Earnings Call May 04, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin (AMRN) Q1 2022 Earnings Call Transcript
Signs that the Federal Reserve won't pursue the most aggressive rate-hiking strategy sparked a late buying spree on Thursday, with the major U.S. equity averages all rising by about 3%. The central bank raised its key rate by 50 basis points, the biggest one-time increase since 2000, but Fed ...
Amarin Corporation plc (AMRN) Q1 2022 Earnings Conference Call May 4, 2022 08:00 ET Company Participants Lisa DeFrancesco - Senior Vice President, Investor Relations and Corporate Affairs Karim Mikhail - President and Chief Executive Officer Steve Ketchum - President, R&D and Chief Scient...
The following slide deck was published by Amarin Corporation plc in conjunction with their 2022 Q1 earnings call. For further details see: Amarin Corporation plc 2022 Q1 - Results - Earnings Call Presentation
ArcelorMittal S.A. (NYSE:MT) is scheduled to announce Q1 earnings results on Thursday, May 5th, before market open. The consensus EPS Estimate is $3.41 (+76.7% Y/Y) and the consensus Revenue Estimate is $20.83B (+28.7% Y/Y). Over the last 1 year, MT has beaten EPS estimates 75% of the time an...
Gainers: Sharps Technology (STSS) +43%. TransMedics Group (TMDX) +30%. Super Micro Computer (SMCI) +25%. CarParts.com (PRTS) +25%. Superior Industries International (SUP) +22%. Livent (LTHM) +23%. Bright Health Group (BHG) +21%. eHealth (EHTH) +19%. BlueLinx Holdings (BXC) +18%. Kimball Inter...
Shares of Amarin (NASDAQ: AMRN) , a pharmaceutical company that markets a fish oil supplement called Vascepa, are under pressure after the company's first-quarter earnings call. Results that missed expectations prompted the market to drag the stock 42.9% lower as of 10:25 a.m. ET on...
Gainers: Bright Health Group BHG +21%. TransMedics Group TMDX +21%. Belite Bio (BLTE) +11%. Sharps Technology STSS +11%. Immutep (IMMP) +7%. Losers: Connect Biopharma CNTB -45%. Amarin AMRN -43%. Kezar Life Sciences (KZR) -35%. MacroGenic...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...